Effects of high-dose imatinib alone or in combination with peginterferon alfa-2b in patients with chronic myeloid leukaemia in early chronic phase.
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2011
At a glance
- Drugs Granulocyte macrophage colony stimulating factor (Primary) ; Imatinib (Primary) ; Peginterferon alfa-2b (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 12 Jan 2011 New trial record